MetaCap

Chemomab Therapeutics Insider Trades

NASDAQ: CMMBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.38-0.01 (-0.72%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
2 · $20.25K
Sales
2 · $6.52K
Shares bought / sold
9.80K / 2.30K
Net activity
Net buying $13,730

Chemomab Therapeutics insider activity

Over the last 12 months, Chemomab Therapeutics insiders reported 6 transactions on SEC Form 4: 2 open-market purchases and 2 sales. Insiders bought $20,246 and sold $6,516 worth of stock, for net insider buying of $13,730. The largest seller was Cohen Neil Harris, with $6,516 in reported sales.

The most recent filing shows Cohen Neil Harris (Director) selling 1,000 shares at $2.80 on Aug 28, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CMMB's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

CMMB insider transactions

Chemomab Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Aug 28, 2026Cohen Neil HarrisDirectorSale1,000$2.80KForm 4
Aug 27, 2026Cohen Neil HarrisDirectorSale1,304$3.72KForm 4
May 29, 2026Mor George AdiChief Executive Officerother18,750—Form 4
May 29, 2026Mor George AdiChief Executive Officerother31,712—Form 4
May 29, 2026Mor George AdiChief Executive OfficerBuy4,926$10.25KForm 4
May 29, 2026Mor George AdiChief Executive OfficerBuy4,878$10.00KForm 4
Jan 3, 2023Mor George AdiChief Scientific OfficerSale6,100$30.66KForm 4
Jan 3, 2023Mor George AdiChief Scientific OfficerSale7,700$38.71KForm 4
Jan 3, 2023OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% OwnerSale70,524$318.06KForm 4
Jan 3, 2023OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% OwnerSale266,376$889.70KForm 4
Nov 16, 2022Mor George AdiChief Scientific OfficerSale257,248$536.31KForm 4
Nov 16, 2022Mor George AdiChief Scientific OfficerSale324,775$677.09KForm 4
Nov 16, 2022Cohen Neil HarrisDirectorSale2,409$4.82KForm 4
May 24, 2022Maryles Joel MichaelDirectorBuy33$91.08Form 4
May 24, 2022Maryles Joel MichaelDirectorBuy400$1.16KForm 4
May 18, 2022Cohen Neil HarrisDirectorBuy2,000$6.38KForm 4
Mar 18, 2022Maryles Joel MichaelDirectorBuy500$2.18KForm 4
Mar 18, 2022Maryles Joel MichaelDirectorBuy500$2.16KForm 4
Mar 16, 2022Marvin DonaldExecutive VP, CFO & COOBuy250$812.50Form 4
Mar 16, 2022Marvin DonaldExecutive VP, CFO & COOBuy250$825Form 4
Mar 14, 2022Cohen Neil HarrisDirectorBuy2,000$9.12KForm 4
Mar 14, 2022Cohen Neil HarrisDirectorBuy2,000$8.60KForm 4
Mar 14, 2022Cohen Neil HarrisDirectorBuy2,000$8.40KForm 4
Mar 14, 2022Pfost Dale RChief Executive OfficerBuy700$2.78KForm 4
Mar 14, 2022Pfost Dale RChief Executive OfficerBuy1,800$7.16KForm 4
Mar 14, 2022Marvin DonaldExecutive VP, CFO & COOBuy250$1.05KForm 4
Mar 14, 2022Marvin DonaldExecutive VP, CFO & COOBuy250$1.02KForm 4
Mar 14, 2022Marvin DonaldExecutive VP, CFO & COOBuy250$975Form 4
Mar 14, 2022Marvin DonaldExecutive VP, CFO & COOBuy250$995Form 4
Mar 14, 2022Marvin DonaldExecutive VP, CFO & COOBuy250$1.00KForm 4
Mar 11, 2022Darvish NissimDirectorBuy1,200$5.14KForm 4
Dec 6, 2021Cohen Neil HarrisDirectorBuy2,000$14.86KForm 4
Mar 16, 2021THIEL PETER10% OwnerBuy230,536—Form 4
Mar 16, 2021OrbiMed Israel GP Ltd. & OrbiMed Israel BioFund GP Limited Partnership10% OwnerAward288,170$5.00MForm 4
Mar 16, 2021Cohen Neil HarrisDirectorBuy2,409$100.00KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related